Promising stem cell research threatened by uncertain funding

Forty nine-year-old Sean Mullin has already passed the $2 million mark in drugs he must take to keep him alive. Fortunately for Mullin, who suffers from a rare form of the deadly lung disease pulmonary arterial hypertension, his wife’s drug plan covers …

[Read the full article here]

Comments are closed.